source
- Ebola therapy development accelerates as multiple candidates enter early trialsA new wave of research teams are racing to develop a therapy for Ebola, according to the latest Morning Rounds newsletter. The article notes that several candidates are now moving into early‑stage…
- FDA CDER appoints veteran GLP-1 reviewer Lisa Yanoff as acting deputy directorActing FDA CDER director Michael Davis promoted Lisa Yanoff to the role of acting deputy director of the Center for Drug Evaluation and Research. Yanoff is a long‑time FDA employee with deep exper…